The discovery of a gene variant that rids the brain of toxic plaques linked to Alzheimer’s might lead to new treatments for the disease, researchers report. The variant arises naturally in people who don’t seem to get Alzheimer’s disease despite having another gene, called APOEe4, that strongly promotes the illness. “These resilient people can tell us a lot about the disease and what genetic and non-genetic factors might provide protection,” explained study co-lead author Badri Vardarajan, an assistant professor of neurological science at Columbia University in New York City. “We hypothesized that these resilient people may have genetic variants that protect them from APOEe4,” Vardarajan added in a university news release. The researchers believe the newly discovered gene variant may reduce the risk for Alzheimer’s by more than 70% in folks lucky enough to carry it. Breaking the blood-brain barrier In their research, Vardarajan and colleagues conducted genomic screening on hundreds of individuals who carried the APOEe4 gene variant, which greatly raises the risk for Alzheimer’s, but who had gone into old age without developing the disease. The found a common variant shared by many of these people. It occurred in a gene charged with making fibronectin, a component used to make the “blood-brain barrier.” That’s the lining that surrounds the brain and helps police which substances can get in and out. People who develop Alzheimer’s tend… read on > read on >

















